116 related articles for article (PubMed ID: 27332908)
1. Fine-Tuning the Treatment of Hodgkin's Lymphoma.
Bartlett NL
N Engl J Med; 2016 Jun; 374(25):2490-2. PubMed ID: 27332908
[No Abstract] [Full Text] [Related]
2. Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
Greaves WO; Bueso-Ramos C; Fayad L
J Clin Oncol; 2011 Feb; 29(4):e76-8. PubMed ID: 21041711
[No Abstract] [Full Text] [Related]
3. [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
Torrent A; Navarro JT; Andreo FC; Ribera JM
Med Clin (Barc); 2013 Aug; 141(3):134-5. PubMed ID: 23332624
[No Abstract] [Full Text] [Related]
4. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
5. Controversies in the treatment of early-stage Hodgkin's lymphoma.
Longo DL; Armitage JO
N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
[No Abstract] [Full Text] [Related]
6. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
7. Using PET-CT to tailor treatment for Hodgkin's lymphoma.
Tanday S
Lancet Oncol; 2016 Aug; 17(8):e322. PubMed ID: 27345638
[No Abstract] [Full Text] [Related]
8. Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy.
Honda A; Nakamura F; Nannya Y; Shintani Y; Fukayama M; Ichikawa M; Kurokawa M
Ann Hematol; 2014 Jun; 93(6):1073-4. PubMed ID: 24173088
[No Abstract] [Full Text] [Related]
9. Escalated BEACOPP in advanced Hodgkin's lymphoma.
Casasnovas O; Coiffier B
Lancet; 2012 May; 379(9828):1767-8. PubMed ID: 22480757
[No Abstract] [Full Text] [Related]
10. Uncommon presentations of Hodgkin's disease. Case 2. Hodgkin's disease of the nasopharynx.
Hollander SL
J Clin Oncol; 2004 Jan; 22(1):195-6. PubMed ID: 14701783
[No Abstract] [Full Text] [Related]
11. Presentation of Hodgkin's lymphoma with Ophelia syndrome.
Olmos D; Rueda A; Jurado JM; Alba E
J Clin Oncol; 2007 May; 25(13):1802-3. PubMed ID: 17470872
[No Abstract] [Full Text] [Related]
12. Pericardial effusion due to pericardium involvement by Hodgkin's lymphoma.
Guastafierro S; Cappabianca S; Falcone U
Ann Hematol; 2013 Jun; 92(6):853-4. PubMed ID: 23196418
[No Abstract] [Full Text] [Related]
13. Hodgkin's lymphoma: better outcomes with fewer drugs?
Casasnovas O; Coiffier B
Lancet; 2015 Apr; 385(9976):1371-3. PubMed ID: 25539731
[No Abstract] [Full Text] [Related]
14. Management of advanced, resistant Hodgkin's disease and non-Hodgkin's lymphoma: a phase II study.
Williams SF; Ultmann JE; Gaynor E; Watson S
Cancer Treat Rep; 1986 Aug; 70(8):1033-4. PubMed ID: 2425964
[No Abstract] [Full Text] [Related]
15. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
[TBL] [Abstract][Full Text] [Related]
16. [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
Baron F; Hermanne JP; Fassotte MF; Beguin Y; Fillet G
Rev Med Liege; 1998 Nov; 53(11):651-3. PubMed ID: 9887654
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Suon SZ
Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
[No Abstract] [Full Text] [Related]
18. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
[No Abstract] [Full Text] [Related]
19. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.
Ypma PF; Wijermans PW; Koppen H; Sillevis Smitt PA
Neth J Med; 2006; 64(7):243-7. PubMed ID: 16929086
[TBL] [Abstract][Full Text] [Related]
20. PET-Directed Therapy for Hodgkin's Lymphoma.
Bishop G
N Engl J Med; 2015 Jul; 373(4):392. PubMed ID: 26200988
[No Abstract] [Full Text] [Related]
[Next] [New Search]